Following these findings, Palomares et al. demonstrated their importance in the context of food allergy where, similarly, IL-10-producing ILC2 s increased following Pru p 3 sublingual immunotherapy for the treatment of LTP allergy [48]. This evidence concerns the gene IL10 and allergic disease.